An Evaluation of Aranesp® in Subjects With Anaemic Chronic Kidney Disease (CKD)

NCT00124098 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Kidney Disease

Interventions

DRUG: Aranesp® (darbepoetin alfa)

Sponsor

Amgen